| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.00015 | 1 |